Table 1.
Comparisons of baseline characteristics.
| Variables | Control group (n=72) | Intervention group (n=80) |
|---|---|---|
| Age (years) | 51.3±10.6 | 50.8±9.9 |
| Male, n (%) | 53 (73.6) | 59 (73.8) |
| Systolic blood pressure, mm Hg | 135±14 | 133±13 |
| Diastolic blood pressure, mm Hg | 80±11 | 80±12 |
| Heart rate, beat per minute | 84±17 | 86±16 |
| Obese, n (%) | 22 (30.6) | 25 (31.3) |
| Smoking, n (%) | 35 (48.6) | 37 (46.3) |
| Hypertension, n (%) | 52 (72.2) | 57 (71.3) |
| Dyslipidemia, n (%) | 48 (66.7) | 53 (66.3) |
| Diabetes mellitus, n (%) | 43 (59.7) | 47 (58.8) |
| Creatinine (umol/L) | 72.4±17.5 | 73.1±15.9 |
| eGFR (ml/min/1.73 m2) | 70.8±14.6 | 69.6±15.5 |
| Glycated hemoglobin A1c (%) | 6.6±1.3 | 6.7±1.3 |
| LDL-cholesterol (mmol/L) | 3.2±0.9 | 3.3±1.0 |
| NT-proBNP (pg/mL) | 908.7±245.1 | 924.0±266.8 |
| Coronary heart disease, n (%) | 45 (62.5) | 49 (61.3) |
| Idiopathic dilated cardiomyopathy, n (%) | 13 (18.1) | 15 (18.8) |
| Valvular heart disease, n (%) | 14 (19.4) | 16 (19.9) |
| Left ventricular ejection fraction, (%) | 39.4±5.0 | 39.0±5.3 |
| NYHA class III–IV, n (%) | 39 (55.7) | 46 (57.5) |
eGFR – estimated glomerular filtration rate; LDL – low density lipoprotein; NT-proBNP – N-terminal pro-B type natriuretic peptide; NYHA – New York Heart Association